Via interestingengineering.com
The chip designer's pivot from licensing to selling its own AI processors is rewriting its financial playbook and opening the door to dealmaking.
Arm Holdings has crossed a threshold that changes the math on everything it can do next. The company’s market capitalization surged past $300 billion in May 2026, peaking at roughly $317 billion on May 21 before settling around $298 billion by mid-August.
From blueprints to building blocks #
The AGI CPU, launched in March 2026, represents Arm’s decisive break from its licensing model. Rather than licensing designs for others to manufacture, Arm is now selling its own chip targeting inference workloads in data centers.
Customer demand has been aggressive. The AGI CPU has already secured more than $2 billion in commitments covering fiscal years 2027 and 2028, a figure that significantly exceeded management’s initial projections. Oracle has signed on as a notable partner, and leading hyperscalers across both North America and China have expressed interest.
Arm’s management is projecting roughly $15 billion in annual AGI CPU revenue by fiscal 2031. Combined with its existing licensing and royalty streams, the company is targeting total revenue of $25 billion by that same year, alongside non-GAAP earnings per share exceeding $9.
Why $300 billion matters for M&A #
Arm has already demonstrated an appetite for dealmaking. The company has completed 26 acquisitions to date. With its valuation now past $300 billion, the scale of targets it can credibly pursue has expanded considerably.
SoftBank’s shadow and the analyst view #
SoftBank holds approximately 87% of Arm’s outstanding shares. For SoftBank, a $300 billion Arm is a vindication of the $32 billion it paid to take the company private back in 2016, with the stake now worth roughly $260 billion on paper.
Bernstein issued an “Outperform” rating with a $300 price target, citing Arm’s dominant position in the evolving AI landscape.
The competitive landscape and what to watch #
What makes Arm’s position unusual is that many of its competitors are also its customers. Nvidia, Qualcomm, and Amazon’s Annapurna Labs all license Arm architecture for various products. Selling chips directly puts Arm in a delicate spot: it needs to compete without alienating the licensees who still generate substantial royalty revenue.
Investors watching this story should track three things. First, whether the $2 billion in AGI CPU commitments converts into actual shipped revenue on schedule. Second, whether Arm announces any significant acquisitions that signal its intent to build a broader AI platform. And third, whether SoftBank’s 87% ownership becomes a governance concern as Arm’s independent strategic ambitions grow.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our